Safety and Efficacy Study of the Combined Ablation Procedure to Treat Paroxysmal Atrial Fibrillation

Exclusion Criteria

• •Patients requiring concomitant surgery
• •Left ventricular ejection fraction \< 30%
• •Pregnant or planning to become pregnant during study
• •Co-morbid medical conditions that limit one year life expectancy
• •Measured left ventricular wall thickness \> 1.5 cm
• •History of coagulopathy
• •Previous cardiac surgery
• •Right ventricular outflow tract obstruction
• •History of pericarditis
• •Previous cerebrovascular accident (CVA), excluding fully resolved TIA
• •Patients who have severe chronic obstructive pulmonary disease (COPD)
• •Patients who have an active infection or sepsis
• •Patients who have uncorrected reversible cause(s) of AF
• •Patients who are contraindicated for anticoagulants
• •Patients who are being treated for arrhythmias other than AF
• •Patients who have had any previous AF or left atrial catheter ablation
• •Current participation in another clinical investigation of a medical device or a drug, or recent participation in such a study within 30 days prior to study enrollment.
• •Not competent to legally represent him or herself (e.g., requires a guardian or caretaker as a legal representative).